Alnylam Pharmaceuticals (ALNY) Technical (Analysis) Reports Alnylam Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Alnylam Pharmaceuticals (ALNY)
Technical Analysis Report for USA stock ALNY Alnylam Pharmaceuticals. Dated: 09 Dec 2025 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock ALNY Alnylam Pharmaceuticals then click here. or read Experts views on Alnylam Pharmaceuticals or Forecast & share price targets of Alnylam Pharmaceuticals
Alnylam Pharmaceuticals Opened at 430.45 and Closed at: 415.21, which is -3.57% of previous session's close. It moved within a range of 412.31 and 433.31
The session was a Bearish session with an average volume of 1610400, which is -49.75% of previous session's volumes.
- Even though the stock has fallen, but its long term trend is positive and in an uptrend.
A Dead cross was found 4 days back on short term averages
Support for tomorrow is 403.26 and resistance for tomorrow is 424.26
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 407.24, 399.28 resistance for tomorrow's hourly charts is 428.24, 441.28
10 Day SMA for Alnylam Pharmaceuticals (ALNY) is 448.76 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Alnylam Pharmaceuticals (ALNY) is 449.77 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Alnylam Pharmaceuticals (ALNY) is 456.29 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 442.68 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Alnylam Pharmaceuticals is 358.69 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Alnylam Pharmaceuticals is at 449.77 and 200 DMA is at 358.69, while 50 DMA and 100 DMA are at 456.29 and 442.68 respectively
Alnylam Pharmaceuticals (ALNY) moving average of 20 SMA is at 449.77 and 20 EMA is at 448.72
| Date | Closing Price | 20 SMA | 20 EMA |
| 09 Tue Dec | 415.21 | 449.77 | 448.72 |
| 08 Mon Dec | 430.02 | 451.1 | 452.25 |
| 05 Fri Dec | 458.12 | 451.73 | 454.59 |
| 04 Thu Dec | 465.34 | 450.85 | 454.22 |
| 03 Wed Dec | 473.29 | 449.31 | 453.05 |
| 02 Tue Dec | 464.93 | 446.82 | 450.92 |
Alnylam Pharmaceuticals (ALNY) moving average of 50 SMA is at 456.29 and 50 EMA is at 448.9
| Date | Closing Price | 50 SMA | 50 EMA |
| 09 Tue Dec | 415.21 | 456.29 | 448.9 |
| 08 Mon Dec | 430.02 | 456.94 | 450.27 |
| 05 Fri Dec | 458.12 | 457.27 | 451.1 |
| 04 Thu Dec | 465.34 | 457.09 | 450.81 |
| 03 Wed Dec | 473.29 | 456.96 | 450.22 |
| 02 Tue Dec | 464.93 | 456.58 | 449.28 |
Alnylam Pharmaceuticals (ALNY) moving average of 100 SMA is at 442.68 and 100 EMA is at 427.84
| Date | Closing Price | 100 SMA | 100 EMA |
| 09 Tue Dec | 415.21 | 442.68 | 427.84 |
| 08 Mon Dec | 430.02 | 441.73 | 428.1 |
| 05 Fri Dec | 458.12 | 440.68 | 428.06 |
| 04 Thu Dec | 465.34 | 439.33 | 427.45 |
| 03 Wed Dec | 473.29 | 437.78 | 426.68 |
| 02 Tue Dec | 464.93 | 436.21 | 425.74 |
Alnylam Pharmaceuticals (ALNY) moving average of 200 SMA is at 358.69 and 200 EMA is at 381.65
| Date | Closing Price | 200 SMA | 200 EMA |
| 09 Tue Dec | 415.21 | 358.69 | 381.65 |
| 08 Mon Dec | 430.02 | 357.87 | 381.31 |
| 05 Fri Dec | 458.12 | 356.97 | 380.82 |
| 04 Thu Dec | 465.34 | 355.93 | 380.04 |
| 03 Wed Dec | 473.29 | 354.86 | 379.18 |
| 02 Tue Dec | 464.93 | 353.77 | 378.23 |
Unitedhealth Group has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Unitedhealth Group, about 6.95% more returns!
Alnylam Pharmaceuticals has performed better than Elanco Animal in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Utah Medical has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Utah Medical, about 5.4% more returns!
Trupanion Inc has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Trupanion Inc, about 6.57% more returns!
Radnet Inc has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Radnet Inc, about 4.75% more returns!
Natera Inc has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Natera Inc, about 22.07% more returns!
Medicinova Inc has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Medicinova Inc, about 3.78% more returns!
Immuron has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Immuron, about 1.34% more returns!
Grifols S has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Grifols S, about 9.16% more returns!
Geron Corporation has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Geron Corporation, about 6.53% more returns!
Fonar Corporation has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Fonar Corporation, about 4.41% more returns!
Eyegate Pharmaceuticals has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Eyegate Pharmaceuticals, about 7.44% more returns!
Coherus Biosciences has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Coherus Biosciences, about 3.69% more returns!
Cidara Therapeutics has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Cidara Therapeutics, about 111.74% more returns!
Angiodynamics Inc has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Angiodynamics Inc, about 12.49% more returns!
Allogene Therapeutics has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Allogene Therapeutics, about 22.65% more returns!
Align Technology has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Align Technology, about 18.17% more returns!
Alnylam Pharmaceuticals Technical analysis of indicators
Price action analysis of Alnylam Pharmaceuticals (ALNY) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
ADX buy sell signal for Alnylam Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Alnylam Pharmaceuticals in short term and the sell signal is strong.
Alnylam Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Alnylam Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Alnylam Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 444.79 and Alnylam Pharmaceuticals ALNY stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Alnylam Pharmaceuticals ALNY stock. Volume based technical analysis of Alnylam Pharmaceuticals ALNY stock is negative.
Alnylam Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock ALNY Alnylam Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And ALNY Experts View which covers a lot of information including buying and selling signals
ALNY future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Alnylam Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Alnylam Pharmaceuticals (ALNY) Technical (Analysis) Reports Alnylam Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance


